New Zealand markets closed

FibroGen, Inc. (FGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2200+0.0900 (+7.96%)
At close: 04:00PM EDT
1.1900 -0.03 (-2.46%)
Pre-market: 05:14AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 120.37M
Enterprise value 92.72M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.71
Price/book (mrq)N/A
Enterprise value/revenue 0.55
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 3-93.00%
S&P500 52-week change 326.43%
52-week high 319.4700
52-week low 30.3330
50-day moving average 31.6599
200-day moving average 31.1996

Share statistics

Avg vol (3-month) 32.36M
Avg vol (10-day) 34.8M
Shares outstanding 599.48M
Implied shares outstanding 699.48M
Float 889.01M
% held by insiders 10.89%
% held by institutions 168.72%
Shares short (15 Apr 2024) 45.43M
Short ratio (15 Apr 2024) 42.72
Short % of float (15 Apr 2024) 46.44%
Short % of shares outstanding (15 Apr 2024) 45.46%
Shares short (prior month 15 Mar 2024) 45.53M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -143.56%
Operating margin (ttm)-55.57%

Management effectiveness

Return on assets (ttm)-34.39%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)167.49M
Revenue per share (ttm)1.70
Quarterly revenue growth (yoy)54.60%
Gross profit (ttm)N/A
EBITDA -241.03M
Net income avi to common (ttm)-240.46M
Diluted EPS (ttm)-2.4400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)177.6M
Total cash per share (mrq)1.78
Total debt (mrq)167.4M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.41
Book value per share (mrq)-2.29

Cash flow statement

Operating cash flow (ttm)-272.72M
Levered free cash flow (ttm)-206.9M